Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 May 2022 for PhaseBio Pharmaceuticals Inc, €7,031. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jonathan P. Mow: trading record in brief
Jonathan P. Mow is a declared insider of PhaseBio Pharmaceuticals Inc (chief executive), with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 20 May 2021 and the latest from 20 May 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 24 May 2022: a share grant of €7,031, in PhaseBio Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jonathan P. Mow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
10,918 shares@ US$0.68135.8% of flowCommon StockSEC:0001169245-22-000078:0
5,623 shares@ US$2.0114.5% of flowCommon StockSEC:0001169245-21-000129:0
20,000 shares@ US$1.2431.2% of flowCommon StockSEC:0001169245-21-000104:0
20,000 shares@ US$1.2430.8% of flowCommon StockSEC:0001169245-21-000085:0
3,964 shares@ US$2.8013.2% of flowCommon StockSEC:0001169245-21-000045:0
5 of 5 declarations
